A revolution in early lung cancer detection is here – and it’s powered by Artificial Intelligence.
RadNet, the nation’s leading provider of outpatient diagnostic imaging services with locations throughout the San Bernardino area, is leading the charge in transforming lung cancer diagnostics by integrating AI into Low-Dose CT (LDCT) screenings – making early, potentially lifesaving detection faster, more accurate, and more personalized than ever.
Lung cancer remains the leading cause of cancer-related death in the United States, largely because it is often discovered only after symptoms develop.
Dr. Dalia Artal, Medical Director of Chest Imaging and Lung Cancer Screening at RadNet, emphasizes that “Low-dose CT screening allows us detect small, early lung cancers that are not visible on X-rays, often long before symptoms ever appear,” noting that “Detecting lung cancer early through screening allows for less invasive treatment options and is associated with significantly improved patient outcomes and survival.” She adds that the availability of LDCT is transforming how clinicians approach lung cancer, shifting the focus from late-stage diagnosis to proactive screening.
Now, with AI-enhanced LDCT, RadNet is raising the bar:
· Greater accuracy: AI sharpens image analysis, helping radiologists catch signs of cancer even earlier.
· Less radiation: Scans use even lower doses, safely.
· Personalized care: AI tools help tailor screenings to individual risk profiles.
As Dr. Artal explains, “By pairing experienced chest radiologists with AI-driven technology, RadNet is ensuring that more patients benefit from earlier and more precise lung cancer detection, when treatment is most effective,” reinforcing RadNet’s commitment to bringing high-quality preventive care into the communities it serves.
The United States Preventative Services Task Force (USPSTF) recommends LDCT lung cancer for adults ages 50 to 80 with a significant smoking history who currently smoke or have quit within the past 15 years. A physician referral is required, and many insurance plans cover the exam for eligible patients (including Medicare, with age criteria 50-77).
Through its focus on early detection and advanced imaging, RadNet continues to support a healthcare model that prioritizes prevention and timely intervention.
For more information about LDCT lung cancer screening or to find a RadNet imaging center near you, visit www.radnet.com.